Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$42,203,147
+$17,306,813 QoQ
Shares Held
35,186
+30.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
#597
of 4,605 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BRADLEY FOSTER & SARGENT INC/CT holds $254,262,538 across 12 Drug Manufacturers - General names. LLY ranks #3 (16.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
333,906 | $84,802,106 | |
| 2 | ABBV |
AbbVie Inc.
|
219,509 | $55,237,244 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
35,186 | $42,203,147 | |
| 4 | MRK |
Merck & Co., Inc.
|
287,164 | $36,900,574 | |
| 5 | PFE |
Pfizer Inc
|
678,377 | $16,335,318 | |
| 6 | AMGN |
Amgen Inc
|
13,889 | $5,029,484 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
38,875 | $4,911,467 | |
| 8 | NVS |
Novartis AG
|
17,635 | $2,763,757 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,203,147 | 35,186 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $24,896,334 | 27,068 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $28,146,946 | 26,191 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $19,626,649 | 25,723 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $19,543,596 | 25,071 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $20,110,082 | 24,349 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $15,202,996 | 19,693 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $18,270,740 | 20,623 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $18,271,473 | 20,181 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $15,265,909 | 19,623 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $11,017,188 | 18,900 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $11,450,537 | 21,318 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $9,997,715 | 21,318 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $7,192,931 | 20,945 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $7,682,640 | 21,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,739,907 | 20,844 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,753,710 | 20,830 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $5,832,497 | 20,367 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,575,860 | 16,566 | Shares | Sole | 2022-03-11 | |
| 2021-09-30 | $3,683,168 | 15,941 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $4,656,731 | 20,289 | Shares | Sole | 2021-08-19 | |
| 2021-03-31 | $3,874,459 | 20,739 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $5,544,536 | 32,839 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $4,868,229 | 32,889 | Shares | Sole | 2020-10-26 | |
| 2020-03-31 | $4,658,078 | 33,579 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||